Methods for treating rheumatoid arthritis and multiple...

Details Methods for treating rheumatoid arthritis and multiple... Methods for treating rheumatoid arthritis and multiple...

2011-07-05

2011-07-05

Mertz, Prema (Department: 1646)

Drug, bio-affecting and body treating compositions

Lymphokine

C514S021200

Reexamination Certificate

active

07972591

ABSTRACT:
The present invention provides polypeptides including MCP1 fused, optionally, by a linker, to an immunoglobulin. Methods for using the polypeptides to treat medical disorders are also covered.

REFERENCES:
patent: 4588585 (1986-05-01), Mark et al.
patent: 4751180 (1988-06-01), Cousens et al.
patent: 5098833 (1992-03-01), Lasky et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5179078 (1993-01-01), Rollins et al.
patent: 5212073 (1993-05-01), Rollins et al.
patent: 5216131 (1993-06-01), Lasky et al.
patent: 5225538 (1993-07-01), Capon et al.
patent: 5278287 (1994-01-01), Rollins et al.
patent: 5359046 (1994-10-01), Capon et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5455165 (1995-10-01), Capon et al.
patent: 5459128 (1995-10-01), Rollins et al.
patent: 5514582 (1996-05-01), Capon et al.
patent: 5532144 (1996-07-01), Yoshimura et al.
patent: 5571713 (1996-11-01), Lyle et al.
patent: 5605671 (1997-02-01), Lyle et al.
patent: 5705360 (1998-01-01), Rollins et al.
patent: 5714147 (1998-02-01), Capon et al.
patent: 5714578 (1998-02-01), Yoshimura et al.
patent: 5739103 (1998-04-01), Rollins et al.
patent: 5840844 (1998-11-01), Lasky et al.
patent: 5854412 (1998-12-01), Rollins et al.
patent: 5932703 (1999-08-01), Godiska et al.
patent: 6001567 (1999-12-01), Brow et al.
patent: 6090795 (2000-07-01), Yoshimura et al.
patent: 6403782 (2002-06-01), Luster et al.
patent: 6406697 (2002-06-01), Capon et al.
patent: 6485910 (2002-11-01), Walker et al.
patent: 6498015 (2002-12-01), Godiska et al.
patent: 6569418 (2003-05-01), Garzino-Demo et al.
patent: 6590075 (2003-07-01), Ruben et al.
patent: 6607879 (2003-08-01), Cocks et al.
patent: 6706471 (2004-03-01), Brow et al.
patent: 6737513 (2004-05-01), Gray et al.
patent: 6767535 (2004-07-01), Rollins et al.
patent: 6780973 (2004-08-01), Luster et al.
patent: 6780982 (2004-08-01), Lyamichev et al.
patent: 6787645 (2004-09-01), Rollins et al.
patent: 6869924 (2005-03-01), Yoshimura et al.
patent: 6878687 (2005-04-01), Ruben et al.
patent: 2002/0009724 (2002-01-01), Schlegel et al.
patent: 2002/0009730 (2002-01-01), Chenchik et al.
patent: 2002/0137081 (2002-09-01), Bandman
patent: 2002/0198362 (2002-12-01), Gaiger et al.
patent: 2003/0073144 (2003-04-01), Benson et al.
patent: 2003/0078396 (2003-04-01), Gaiger et al.
patent: 2003/0099974 (2003-05-01), Lillie et al.
patent: 2003/0129214 (2003-07-01), Bornstein et al.
patent: 2003/0143220 (2003-07-01), Capon et al.
patent: 2003/0162737 (2003-08-01), Egashira et al.
patent: 2003/0166903 (2003-09-01), Astromoff et al.
patent: 2003/0175704 (2003-09-01), Lasek et al.
patent: 2004/0002068 (2004-01-01), Gaiger et al.
patent: 2004/0029179 (2004-02-01), Koentgen
patent: 2004/0031072 (2004-02-01), La Rosa et al.
patent: 2004/0077835 (2004-04-01), Offord et al.
patent: 2004/0110792 (2004-06-01), Raponi
patent: 2004/0157253 (2004-08-01), Xu et al.
patent: 2004/0177387 (2004-09-01), Jayakrishna
patent: 2004/0224875 (2004-11-01), Schilling et al.
patent: 2004/0248169 (2004-12-01), Liew
patent: 2004/0265808 (2004-12-01), Garcia et al.
patent: 2005/0058635 (2005-03-01), Demuth et al.
patent: 2005/0058639 (2005-03-01), Gudas et al.
patent: 2005/0232923 (2005-10-01), Yan et al.
patent: 2006/0263774 (2006-11-01), Clark et al.
patent: 2152141 (1996-12-01), None
patent: 2343602 (2001-10-01), None
patent: 1144845 (2000-05-01), None
patent: 1435433 (2003-08-01), None
patent: 2003310272 (2003-11-01), None
patent: 2004307427 (2004-11-01), None
patent: WO90/07863 (1990-07-01), None
patent: WO92/19737 (1992-11-01), None
patent: WO95/04158 (1995-02-01), None
patent: WO95/09232 (1995-04-01), None
patent: WO95/13295 (1995-05-01), None
patent: WO95/19167 (1995-07-01), None
patent: WO98/45435 (1998-10-01), None
patent: WO99/05297 (1999-02-01), None
patent: WO99/12968 (1999-03-01), None
patent: WO00/04926 (2000-02-01), None
patent: WO00/09525 (2000-02-01), None
patent: WO00/21991 (2000-04-01), None
patent: WO00/42071 (2000-07-01), None
patent: WO01/46697 (2001-06-01), None
patent: WO02/18413 (2002-03-01), None
patent: WO02/066510 (2002-08-01), None
patent: WO02/068579 (2002-09-01), None
patent: WO02/085308 (2002-10-01), None
patent: WO02/085309 (2002-10-01), None
patent: WO03/082920 (2003-10-01), None
patent: WO03/083059 (2003-10-01), None
patent: WO03/084993 (2003-10-01), None
patent: WO03/091391 (2003-11-01), None
patent: WO2004/022778 (2004-03-01), None
patent: WO2004/031233 (2004-04-01), None
patent: WO2004/065545 (2004-08-01), None
patent: WO2004/078777 (2004-09-01), None
patent: WO2004/080273 (2004-09-01), None
patent: WO2004/092368 (2004-10-01), None
patent: WO2004/096850 (2004-11-01), None
patent: WO2004/097052 (2004-11-01), None
patent: WO2004/112829 (2004-12-01), None
patent: WO2004/113522 (2004-12-01), None
patent: WO2005/002416 (2005-01-01), None
patent: WO2005/037305 (2005-04-01), None
patent: WO2007/113285 (2007-10-01), None
patent: WO03/37376 (2007-12-01), None
Chintalacharuvu et al. Hybrid IgA2/IgG1 antibodies with tailor-made effector functions. Clin Immunol. Oct. 2001;101(1):21-31.
Esposito & Chatterjee. Enhancement of soluble protein expression through the use of fusion tags. Curr Opin Biotechnol. Aug. 2006;17(4):353-8.
Ferrara et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med. Mar. 1998;4(3):336-40.
Gerber et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. Jun. 1999;5(6):623-8.
Hilbert et al. Pharmacokinetics ABS pharmacodynamics of BIWH 3 in healthy duffy antigen positive and duffy antigen negative male volunteers. Am. Soc. Clin. Pharm. Therap. 2006. PII-60.
Holash et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A. Aug. 20, 2002;99(17):11393-8.
Kurlander & Batker. The binding of human immunoglobulin G1 monomer and small, covalently cross-linked polymers of immunoglobulin G1 to human peripheral blood monocytes and polymorphonuclear leukocytes. J Clin Invest. Jan. 1982;69(1):1-8.
Ohtsuki et al. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation. Jul. 10, 2001;104(2):203-8.
Pashine et al. Failed efficacy of soluble human CD83-Ig in allogeneic mixed lymphocyte reactions and experimental autoimmune encephalomyelitis: implications for a lack of therapeutic potential. Immunol Lett. Jan. 15, 2008;115(1):9-15. Epub Nov. 29, 2007.
Saphire et al. Contrasting IgG structures reveal extreme asymmetry and flexibility. J Mol Biol. May 24, 2002;319(1):9-18.
Terpe. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol. Jan. 2003;60(5):523-33.
Unanue & Benacerraf. Textbook of Immunology (2d ed.). Williams & Wilkins, Baltimore/London. 1984. pp. 46-51.
Genbank accession No. BC025985 (released Mar. 22, 2002).
Genbank accession No. BC057688 (released Sep. 16, 2003).
Genbank accession No. NM—002982; derived from S71513.1 (released May 7, 1993).
Genbank accession No. NM—009915; derived from U56819.1 (released Sep. 12, 1996).
Genbank accession No. NM—006274; derived from AB000887.1 (released Jun. 6, 1997).
Genbank accession No. NP—002975; derived from AY766446.1 (released Oct. 1, 2005).
Genbank accession No. NP—006265; derived from AB000887.1 (released Jun. 6, 1997).
Genbank accession No. NP—954637; derived from BC031072.1 (released Jun. 13, 2002).
Brodmerkel, Carrie M., et al.; “Discovery and Pharmacological Characterizatin of a Novel Rodent-Active CCR2 Antagonist, INCB3344”; The Journal of Immunology; 175:5370-5378 (2005).
Chou, Chuan-Chu, et al.; “Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1β”; British Journal of Pharmacology; 137:663-675 (2002).
Conti, Ilaria, et al.; “CCL2 (monocyte chemoattractant protein-1) and cancer”; Seminars in Cancer Biology; 14:149-154

Affiliated with

Also associated with

Rating

Methods for treating rheumatoid arthritis and multiple... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating rheumatoid arthritis and multiple..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating rheumatoid arthritis and multiple... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2669530